1470
M. Weitman et al. / Tetrahedron 66 (2010) 1465–1471
(1H, s, HC–CO), 7.40 (1H, m, H-p), 7.48 (3H, m, H-m, H-5), 7.54 (1-H,
s, H-2), 7.64 (3H, m, H-o, H-4), 7.86 (2H, br s NH2). 13C NMR
6.2 (1H, br s, NH), 7.11 (1H, br s, NH), 7.34 (3H, m, H-aromatic), 7.42
(3H, m, H-aromatic), 7.51 (1H, s, CH-imidazole), 7.62 (3H, m, H-
(75.5 MHz, CDCl3):
d
¼82.5 (CH–O), 111.5 (C–OH), 124.8, 125.3, 126.5,
aromatic). 13C NMR (75.5 MHz, acetone-d6):
d¼31.3 (CH2), 125.6,
126.7, 127.6, 129.05, 129.09, (CH-aromatic), 138.0 (C-ipso CH), 139.9,
140.3 (C-ipso biphenyl, C-ipso biphenyl) 172.7 (CONH2), 182.5 (CO
ketone). MS (CIþ) m/z (%) 267.09 (MHþ, 0.63), 250.08 (MHþꢃH2O,
0.42). HRMS calcd for C16H13NO3 267.0900; found 267.092.
127.7, 128.10, 128.16, 128.56, 129.63, 129.77 (CH-aromatic) 134.33,
134.55 (CCONH2, CH-imidazole). At the concentration of the
sample, the quaternary (CCONH2 and CCH2) were not observed.
4.1.10. Methyl 4-(3-iodophenyl)oxazole-5-carboxylate (16). A solu-
tion of methyl 2-bromo-3-(3-iodophenyl)-3-oxopropanoate
(2.61 mmol)informamide(1 mL)towhich0.1 mL of waterwasadded
was heated at 140 ꢂC for 5 h. Na2CO3 1 M and CHCl3 were then added
and the organic phase was separated, dried over MgSO4 and evapo-
rated. The residue was purified by chromatography (hexane/EtOAc
20:1) to provide 16 as a white solid in 2.3% yield. 1H NMR (300 MHz,
4.1.4. 2,2-Dihydroxy-3-oxo-4-phenylbutanamide (4a)4,5
(75.5 MHz, CDCl3):
(C-m), 130.7 (C-o), 135.3 (C-ipso), 172.1 (CONH2), 204.3 (CO ketone).
MS (CIþ) (%) 192.067 (MHþ, 15), 174.06 (MþꢃNH3, 7.5) 147.048 (Mþ-
CONHþ2 , 100), 119.06 (BnCOþ, 16.3). HRMS calcd for C10H10NO3
192.066; found 192.067.
.
13C NMR
d
¼42.7 (CH2), 95.4 (C(OH)2), 127.4 (C-p), 128.9
CDCl3):
8 (1H s,), 7.76 (1H, ddd, J¼8.14; 1.73; 1 Hz), 7.19 (1H, t, J¼8.2 Hz), 3.94
(3H s,). 13C NMR (150.9 MHz, CDCl3/acetone-d6):
d
¼8.46 (1H, t, J¼1.73 Hz), 8.08 (1H, ddd, J¼8.14; 1.73; 1 Hz, H),
4.1.5. 4-(3-Bromophenyl)-2,2-dihydroxy-3-oxobutanamide
(4b)4,5. Compound 4b was obtained as a pale white solid yield from
compound 3b as described and was found to be mixed with
residual unreacted 3b. The diagnostic 1H NMR peak for 3b is the
HC–CO found at 5.72 ppm, whereas that of the product 4b is the
CH2 found at 4.08 ppm.
d¼159.3, 153.8,
144.56, 139.26, 138.65, 138, 133.16, 130.9, 129.32, 94.03, 52.67.
4.2. Computational methods
The structures of compounds 6a (tautomers A and B), 7 (tau-
tomers A and B), 12, and oxazole were optimized with the
mPW1PW91 density functional19 in conjunction with the 6-31G(d)
basis set.20–22 Frequency calculations were performed to analyze
the nature of the stationary points, and local minima were verified.
Thermal corrections were added employing standard statistical
mechanics equations.23 The frequencies were scaled by 0.9547.24
Single-point energies were calculated at the mPW1PW91/6-
311þþG(3df,2p) level.25,26 To obtain tautomerization free energies,
the mPW1PW91/6-311þþG(3df,2p) level energies were combined
with the mPW1PW91/6-31G(d) level zero-point energy and ther-
mal corrections. To verify the reliability of the mPW1PW91 func-
tional, test calculations on compound 12 (tautomers A and B) with
the above functional as well as the B1B9527 and BB1K28 functionals
and second-order perturbation theory calculations (MP2) were
conducted with the 6-31þG(d,p) basis set. All four methods favored
tautomer B by a 1.4–1.6 kcal/mol potential energy difference (see
Supplementary data).
To obtain the computational shielding data, the GIAO method
was employed. In this method, the nuclear shielding is computed as
the second derivative of the energy with respect to the applied
magnetic field and the nuclear moment using field dependent
atomic orbitals.29,30 The mPW1PW91 density functional was
employed as it has been shown to give good accord with experi-
mental spectra.31 The 6-311þG(2d,p) basis set was chosen as it was
found suitable for nuclear shielding calculations.32
4.1.6. 4-(Biphenyl-3-yl)-2,2-dihydroxy-3-oxobutanamide
(4c)4,5. Compound 4c was obtained as a pale yellow solid in 35%
yield from compound 3c as described:4,5 mp 90–92 ꢂC. 1H NMR
(300 MHz, acetone-d6):
(1H, br s, NH), 7.34 (9H, m, H-aromatic, NH). 13C NMR (75.5 MHz,
CD3OD):
d
¼4.11 (2H, s, CH2), 6.15 (1H, br s, OH) 7.2
d
¼41.4 (CH2), 97.3 (C(OH)2), 123.8, 125.4, 125.7, 127.0,
127.12, 127.15, 127.27 (CH-aromatic),133.3 (C-ipso to the methylene),
139.7, 137.9 (C-ipso to the biphenyl), 169.8 (CONH2), 202.1 (CO
ketone). MS (CIþ) m/z (%) 267.09 (MꢃH2O, 7.4), 212.06 (Ph–Bn–
COOH, 40.6). HRMS calcd for C16H13NO3 267.090; found 267.093.
4.1.7. 3-Hydroxy-2-oxo-4-phenylbut-3-enamide (5a)4,5. Compound
5a was obtained as a pale yellow solid, mp 165–167 ꢂC, in 93% yield
upon evaporation of a solution of 4a in acetone. 1H NMR (300 MHz,
acetone-d6):
d
¼7.06 (1H, s, enol), 7.36 (3H, m, H-m, H-p), 7.93 (2H,
m, o). 13C NMR (75.5 MHz, CDCl3):
d
¼118.8 (CH enolic), 128.5 (C-m),
128.8 (C-p), 130.7 (C-o), 134.6 (C-ipso), 146.9 (COH enolic), 165.3
(CONH2), 184.6 (CO ketone).
4.1.8. 4-Benzyl-1H-imidazole-5-carboxamide (6a). A solution of 4a
(0.1 g, 0.34 mmol) hexamethylenetetramine (0.1 g, 0.69 mmol),
NH4OAc (26 mg, 0.34 mmol) in acetic acid (1.5 mL) was heated with
stirring at 165 ꢂC for 5 min under microwave irradiation conditions.
The mixture was poured into a saturated aqueous NH4OH solution
cooled to 0 ꢂC. The brown precipitate formed was filtered and the
filtrate was extracted with EtOAc. The organic phase was dried
(MgSO4), filtered and evaporated to give a brown residual oil, which
was purified by flash chromatography (EtOAc). Compound 6a was
isolated as white needles (crystallized from acetone) in 4% yield
(microwave irradiation) or 7% yield (thermal conditions, 1 h at
165 ꢂC, using the same workup). 1H NMR (600 MHz, acetone-d6):
The quantity computed by the DFT-GIAO calculations is the
shielding of the nuclei by the electrons. The experimentally
observed chemical shift for carbon atoms, dC, is related to the
computed shielding sC by sC¼186.4ꢃdC where the experimentally
determined shielding of tetramethylsilane (TMS) has been
employed.33 The experimentally observed chemical shift for
d
¼4.48 (2H, s, CH2), 6.28 (1H, br s, NH), 7.15 (1H, br s, NH), 7.16 (1H,
hydrogens, dH, is related to the computed shielding sH by
t, J¼7.2 Hz, H-p), 7.25 (2H, t, J¼7.2 Hz, H-m), 7.3 (2H, d, J¼7.2 Hz, H-
sH¼196.1ꢃdH where the computed shielding of TMS has been
o), 7.50 (1H, s, CH-imidazole). 13C NMR (150.9 MHz, acetone-d6):
employed. All calculations employed the Gaussian 03 program.34
d
¼30.3 (CH2), 126.0 (C-p), 128.2 (C-m), 128.5 (C-o), 130.4 (C-m),
Acknowledgements
138.2 (C-ipso), 133.5 (CH-imidazole), 133.7 (CCONH2) 139.6 (Bn-C),
165.2 (CONH2). MS (CIþ) m/z (%) 202.10 (MHþ, 4), 185.068
(MHþꢃNH3, 2), 159.10 (MHþꢃCONH3, 0.81). HRMS (MHþ) calcd for
C11H12N3O 202.098; found 202.097.
We thank the ‘Marcus Center for Pharmaceutical and Medicinal
Chemistry’ at Bar Ilan University.
4.1.9. 4-(Biphenyl-3-ylmethyl)-1H-imidazole-5-carboxamide
(6c). Compound 6c prepared from 4c was isolated as described for
6a, as a yellow oil in 7% yield (microwave irradiation or thermal
Supplementary data
Tables of geometries and potential energies for molecules 6, 7,
12, and oxazole. Table of tautomerization energies for compound 12
conditions). 1H NMR (300 MHz, acetone-d6):
d¼4.50 (2H, s, CH2),